Evaluation of somatostatin-receptor scintigraphy for detecting neuroendocrine tumors

This publication has 12 references indexed in Scilit:

• Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome
  European Journal of Nuclear Medicine and Molecular Imaging, 1994
• Somatostatin receptor scintigraphy: Its value in tumor localization in patients with cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion
  The American Journal of Medicine, 1994
• Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: A comparative study
  Clinical Radiology, 1993
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• In vivo somatostatin receptor imaging in medullary thyroid carcinoma
  Journal of Clinical Endocrinology & Metabolism, 1993
• Localization of neuroendocrine tumours and insulinomas using radiolabeled somatostatin analogues, ¹²³ I‐Try³‐octreotide and ¹¹¹in‐pentatreitide
  Clinical Endocrinology, 1993
• Somatostatin analogue scintigraphy in carcinoid tumours
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• The Visualization of Gastroenteropancreatic Endocrine Tumors
  Digestion, 1993
• Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic Cholera
  New England Journal of Medicine, 1985
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982